Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2012
03/29/2012US20120077184 Electromagnetic multiplex assay biosensor
03/29/2012US20120077181 Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies
03/29/2012US20120076871 Method for detecting, quantifying and mapping damage and/or repair of dna strands
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076830 Differentiation of stem cells with nanoparticles
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076811 Immunodominant compositions and methods of use therefor
03/29/2012US20120076797 Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulation
03/29/2012US20120076794 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
03/29/2012US20120076788 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
03/29/2012US20120076763 Combination anti-hiv vectors, targeting vectors, and methods of use
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076731 Lymphedema associated genes and model
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012US20120076729 Methods of treating cancers
03/29/2012US20120076725 Lung cancer markers, and uses thereof
03/29/2012US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/29/2012US20120076722 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression
03/29/2012US20120073585 Methods of predicting complication and surgery in crohn's disease
03/29/2012DE19648719B4 Verfahren zum Prüfen von manometrischen Meßgeräten für die Messung des biochemischen Sauerstoffbedarfs Method for testing manometric instruments for the measurement of biochemical oxygen demand
03/29/2012DE102010046866A1 Diagnosing diseases of central nervous system e.g. primary lymphoma, comprises determining content of microRNA highly diagnostic for presence or absence of disease in a sample of cerebrospinal fluid, and comparing with a reference value
03/29/2012DE102008011283B4 Markerfreies Chromosomenscreening Marker chromosome Free Screening
03/29/2012DE102005001889B4 Verfahren zur Steigerung der Bindungskapazität und -effizienz eines Proteins, das nicht methylierte CPG-Motive enthaltende DNA spezifisch bindet A method for enhancing the capacity and efficiency of a binding protein which specifically binds non-methylated CpG motifs containing DNA
03/29/2012CA2843590A1 Quantitation of human genomic and mitochondrial dna
03/29/2012CA2812416A1 Human b1 cells and uses thereof
03/29/2012CA2812287A1 Direct blood assay for detection of circulating microrna in cancer patients
03/29/2012CA2811878A1 Method for producing cruciferous plant resistant to clubroot
03/29/2012CA2811810A1 Methods and apparatus for amplifying nucleic acids
03/29/2012CA2811716A1 A method for detecting, quantifying and mapping damage and/or repair of dna strands
03/29/2012CA2811654A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012CA2811558A1 Breast cancer diagnostics
03/29/2012CA2811381A1 Sulfonated coumarins, synthesis thereof, fluorogenic substrates resulting from grafting said coumarins onto sugars, method for preparing said substrates, and uses thereof
03/29/2012CA2811297A1 Method of recombinant macromolecular production
03/29/2012CA2810931A1 Direct capture, amplification and sequencing of target dna using immobilized primers
03/28/2012EP2434290A1 Blood coagulation time prolonging agent
03/28/2012EP2434285A1 Breast cancer diagnostics
03/28/2012EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
03/28/2012EP2434024A1 Urine markers for detection of bladder cancer
03/28/2012EP2434023A1 Urine markers for detection of bladder cancer
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2434021A1 Apparatus and method for evaluating characteristics of target molecules
03/28/2012EP2434010A1 Prophylactic and/or therapeutic agent for metabolic syndrome
03/28/2012EP2434008A1 Laccases for pulp bio-bleaching
03/28/2012EP2433962A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433961A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433960A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433959A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433958A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433957A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433956A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433955A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433954A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433950A1 DNA sequencing by parallel oligonucleotide extensions
03/28/2012EP2433949A1 DNA sequencing by parallel oligonucleotide extensions
03/28/2012EP2433134A1 Assay methods for the determination of fkbpl expression level in the context of breast cancer
03/28/2012EP2433131A1 Particles and methods for long wavelength sers
03/28/2012EP2433130A2 Device and method for isolating biological or chemical targets
03/28/2012EP2432900A2 Methods and compositions relating to fusions of alk for diagnosing and treating cancer
03/28/2012EP2432899A1 Sorting asymmetrically tagged nucleic acids by selective primer extension
03/28/2012EP2432898A1 Genetic markers associated with interferon-alpha response
03/28/2012EP2432897A1 Methods for whole-cell analysis of gram-positive bacteria
03/28/2012EP2432896A1 A method for predicting the responsiveness of a patient to a treatment with an anti-cd20 antibody and a method for diagnosing rheumatoid arthritis
03/28/2012EP2432895A2 Mirna biomarkers of prostate disease
03/28/2012EP2432894A1 Glucose sensor calibration
03/28/2012EP2432893A1 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs
03/28/2012EP2432882A2 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
03/28/2012EP2432881A2 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/28/2012EP2432880A1 Targeting micrornas for metabolic disorders
03/28/2012EP2432873A1 A dried and stabilized ready-to-use composition containing nucleic acid polymerization enzymes for molecular biology applications
03/28/2012EP2432800A2 Marked peptides and use thereof for assaying circulating irap
03/28/2012EP2432796A2 Universal tags with non-natural nucleobases
03/28/2012EP2432795A1 Dna glycosylase/lyase and ap endonuclease substrates
03/28/2012EP2432793A2 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
03/28/2012EP2432782A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
03/28/2012EP2432579A2 Forming sample combinations using liquid bridge systems
03/28/2012EP2432496A1 Control of uric acid homeostasis
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2231693B1 Polypeptide libraries with a predetermined scaffold
03/28/2012EP2050819B1 Method for amplification of nucleotide sequence
03/28/2012EP2011882B1 Method for screening of substance capable of increasing glutathione
03/28/2012EP1954706B1 Method using reversibly blocked tagging oligonucleotides
03/28/2012EP1877584B1 Feline hemoplasma isolate
03/28/2012EP1877581B1 Methods and products for nucleic acid target capture
03/28/2012EP1766077B1 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
03/28/2012EP1751302B1 Analyte sensors and methods for making and using them
03/28/2012EP1720010B1 Amino acid biosensor and fischer ratio biosensor
03/28/2012EP1718757B1 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation
03/28/2012EP1694775B1 Reagent for detecting an analyte
03/28/2012EP1592802B1 Polymeric membranes for use in electrochemical sensors
03/28/2012EP1478395B1 Rapid lateral flow assay for determining exposure to mycobacterium tuberculosis and other mycobacteria
03/28/2012EP1392866B1 Novel method for cloning variable domain sequences of immunological gene repertoire
03/28/2012EP1073895B1 Dextran-coated surface
03/28/2012CN202175682U 梅毒螺旋体实时荧光定量pcr多靶检测试剂盒 Treponema pallidum real-time quantitative pcr multi-target detection kit
03/28/2012CN1780920B Gene expression suppression agents
03/28/2012CN102395687A Genetic loci associated with fusarium ear mold resistance in maize
03/28/2012CN102395686A Method of amplification of gc-rich dna templates
03/28/2012CN102395685A Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
03/28/2012CN102395684A Target substance detection method using aptamer
03/28/2012CN102395683A Imprinting in very small embryonic-like (vsel) stem cells
03/28/2012CN102395682A Tumor grading and cancer prognosis